Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ
Chih‐Hao Lee, Ajay Chawla, Ned Urbiztondo et al. · Science · 2003
The formation of an atherosclerotic lesion is mediated by lipid-laden macrophages (foam cells), which also establish chronic inflammation associated with lesion progression. The peroxisome proliferator-activated receptor (PPAR) gamma promotes lipid uptake and efflux in these atherogenic cells. In contrast, we found that the closely related receptor PPARdelta controls the inflammatory status of the macrophage. Deletion of PPARdelta from foam cells increased the availability of inflammatory suppressors, which in turn reduced atherosclerotic lesion area by more than 50%. We propose an unconventional ligand-dependent transcriptional pathway in which PPARdelta controls an inflammatory switch through its association and disassociation with transcriptional repressors. PPARdelta and its ligands may thus serve as therapeutic targets to attenuate inflammation and slow the progression of atherosclerosis.
Cited by 580 works. doi:10.1126/science.1087344
Authors
References
- Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis
- Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice
- Control of Inflammation, Cytokine Expression, and Germinal Center Formation by BCL-6
- PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
- A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis
- A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport
- MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B
- Innate and acquired immunity in atherogenesis
- Synthetic LXR ligand inhibits the development of atherosclerosis in mice
- Exchange of N-CoR Corepressor and Tip60 Coactivator Complexes Links Gene Expression by NF-κB and β-Amyloid Precursor Protein